Nanoparticles of ZnO/Berberine complex contract COVID-19 and respiratory co-bacterial infection in addition to elimination of hydroxychloroquine toxicity

PURPOSE: A novel coronavirus (COVID-19) that has not been previously identified in humans and has no specific treatment has recently spread. Treatment trials using antiviral and immune-modulating drugs such as hydroxychloroquine (HCQ) were used to control this viral outbreak however several side eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghareeb, Doaa A., Saleh, Samar R., Seadawy, Mohamed G., Nofal, Mohammed S., Abdulmalek, Shaymaa A., Hassan, Salma F., Khedr, Shaimaa M., AbdElwahab, Miral G., Sobhy, Ahmed A., Abdel-Hamid, Ali saber Ali, Yassin, Abdelrahman Mohamed, Elmoneam, Alshimaa A. Abd, Masoud, Aliaa A., Kaddah, Mohamed M. Y., El-Zahaby, Sally A., Al-mahallawi, Abdulaziz Mohsen, El-Gharbawy, Alaa M., Zaki, Ahmed, Seif, Inas k., Kenawy, Marwa Y., Amin, Magdy, Amer, Khaled, El Demellawy, Maha Adel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419391/
https://www.ncbi.nlm.nih.gov/pubmed/34513113
http://dx.doi.org/10.1007/s40005-021-00544-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419391/
https://www.ncbi.nlm.nih.gov/pubmed/34513113
http://dx.doi.org/10.1007/s40005-021-00544-w

Ejemplares similares